<!DOCTYPE html>
<!--[if lt IE 7 ]><html class="ie ie6" lang="en"> <![endif]-->
<!--[if IE 7 ]><html class="ie ie7" lang="en"> <![endif]-->
<!--[if IE 8 ]><html class="ie ie8" lang="en"> <![endif]-->
<!--[if (gte IE 9)|!(IE)]><!--><html lang="en"> <!--<![endif]-->
<head>
<title>COVID-19 Registered Trials - and analysis - CEBM</title>
<meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=3.0" />

<!-- ================ CSS ================ -->
<link rel="stylesheet" href="https://www.cebm.net/wp-content/themes/cebm-redux/css/skeleton.css?v=2">
<link rel="stylesheet" href="https://www.cebm.net/wp-content/themes/cebm-redux/css/layout.css?v=2">
<link rel="stylesheet" href="https://www.cebm.net/wp-content/themes/cebm-redux/css/print.css?v=2" media="print">
<link href='//fonts.googleapis.com/css?family=Montserrat:400,700' rel='stylesheet' type='text/css'>

<link rel="shortcut icon" href="https://www.cebm.net/wp-content/themes/cebm-redux/images/favicon.ico">

<!--[if lt IE 9]>
<script src="//html5shim.googlecode.com/svn/trunk/html5.js"></script>
<![endif]-->


<!-- Social Warfare v3.6.1 https://warfareplugins.com --><style>@font-face {font-family: "sw-icon-font";src:url("https://www.cebm.net/wp-content/plugins/social-warfare/assets/fonts/sw-icon-font.eot?ver=3.6.1");src:url("https://www.cebm.net/wp-content/plugins/social-warfare/assets/fonts/sw-icon-font.eot?ver=3.6.1#iefix") format("embedded-opentype"),url("https://www.cebm.net/wp-content/plugins/social-warfare/assets/fonts/sw-icon-font.woff?ver=3.6.1") format("woff"),
	url("https://www.cebm.net/wp-content/plugins/social-warfare/assets/fonts/sw-icon-font.ttf?ver=3.6.1") format("truetype"),url("https://www.cebm.net/wp-content/plugins/social-warfare/assets/fonts/sw-icon-font.svg?ver=3.6.1#1445203416") format("svg");font-weight: normal;font-style: normal;}</style>
<!-- Social Warfare v3.6.1 https://warfareplugins.com -->


<!-- This site is optimized with the Yoast SEO plugin v13.3 - https://yoast.com/wordpress/plugins/seo/ -->
<meta name="robots" content="max-snippet:-1, max-image-preview:large, max-video-preview:-1"/>
<link rel="canonical" href="https://www.cebm.net/oxford-covid-19/covid-19-registered-trials-and-analysis/" />
<meta property="og:locale" content="en_GB" />
<meta property="og:type" content="article" />
<meta property="og:title" content="COVID-19 Registered Trials - and analysis - CEBM" />
<meta property="og:description" content="COVID-19 trials registered up to 8 March 2020&mdash;an analysis of 382 studies Jeff Aronson, Robin Ferner, Nicholas DeVito, Carl Heneghan" />
<meta property="og:url" content="https://www.cebm.net/oxford-covid-19/covid-19-registered-trials-and-analysis/" />
<meta property="og:site_name" content="CEBM" />
<meta property="og:image" content="https://www.cebm.net/wp-content/uploads/2020/03/Registered-trials.png" />
<meta property="og:image:secure_url" content="https://www.cebm.net/wp-content/uploads/2020/03/Registered-trials.png" />
<meta name="twitter:card" content="summary_large_image" />
<meta name="twitter:description" content="COVID-19 trials registered up to 8 March 2020&mdash;an analysis of 382 studies Jeff Aronson, Robin Ferner, Nicholas DeVito, Carl Heneghan" />
<meta name="twitter:title" content="COVID-19 Registered Trials - and analysis - CEBM" />
<meta name="twitter:image" content="https://www.cebm.net/wp-content/uploads/2020/03/Registered-trials.png" />
<meta name="twitter:creator" content="@cebmblog" />
<script type='application/ld+json' class='yoast-schema-graph yoast-schema-graph--main'>{"@context":"https://schema.org","@graph":[{"@type":"WebSite","@id":"https://www.cebm.net/#website","url":"https://www.cebm.net/","name":"CEBM","inLanguage":"en-GB","description":"The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare.","potentialAction":[{"@type":"SearchAction","target":"https://www.cebm.net/?s={search_term_string}","query-input":"required name=search_term_string"}]},{"@type":"ImageObject","@id":"https://www.cebm.net/oxford-covid-19/covid-19-registered-trials-and-analysis/#primaryimage","inLanguage":"en-GB","url":"https://www.cebm.net/wp-content/uploads/2020/03/Registered-trials.png","width":1200,"height":600},{"@type":"WebPage","@id":"https://www.cebm.net/oxford-covid-19/covid-19-registered-trials-and-analysis/#webpage","url":"https://www.cebm.net/oxford-covid-19/covid-19-registered-trials-and-analysis/","name":"COVID-19 Registered Trials - and analysis - CEBM","isPartOf":{"@id":"https://www.cebm.net/#website"},"inLanguage":"en-GB","primaryImageOfPage":{"@id":"https://www.cebm.net/oxford-covid-19/covid-19-registered-trials-and-analysis/#primaryimage"},"datePublished":"2020-03-17T14:52:41+00:00","dateModified":"2020-03-19T07:34:00+00:00","potentialAction":[{"@type":"ReadAction","target":["https://www.cebm.net/oxford-covid-19/covid-19-registered-trials-and-analysis/"]}]}]}</script>
<!-- / Yoast SEO plugin. -->

<link rel='dns-prefetch' href='//fonts.googleapis.com' />
<link rel='dns-prefetch' href='//s.w.org' />
<link rel="alternate" type="application/rss+xml" title="CEBM &raquo; Feed" href="https://www.cebm.net/feed/" />
<link rel="alternate" type="application/rss+xml" title="CEBM &raquo; Comments Feed" href="https://www.cebm.net/comments/feed/" />
<!-- This site uses the Google Analytics by ExactMetrics plugin v6.0.2 - Using Analytics tracking - https://www.exactmetrics.com/ -->
<script type="text/javascript" data-cfasync="false">
	var em_version         = '6.0.2';
	var em_track_user      = true;
	var em_no_track_reason = '';
	
	var disableStr = 'ga-disable-UA-1567229-1';

	/* Function to detect opted out users */
	function __gaTrackerIsOptedOut() {
		return document.cookie.indexOf(disableStr + '=true') > -1;
	}

	/* Disable tracking if the opt-out cookie exists. */
	if ( __gaTrackerIsOptedOut() ) {
		window[disableStr] = true;
	}

	/* Opt-out function */
	function __gaTrackerOptout() {
	  document.cookie = disableStr + '=true; expires=Thu, 31 Dec 2099 23:59:59 UTC; path=/';
	  window[disableStr] = true;
	}

	if ( 'undefined' === typeof gaOptout ) {
		function gaOptout() {
			__gaTrackerOptout();
		}
	}
	
	if ( em_track_user ) {
		(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
			(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
			m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
		})(window,document,'script','//www.google-analytics.com/analytics.js','__gaTracker');

window.ga = __gaTracker;		__gaTracker('create', 'UA-1567229-1', 'auto');
		__gaTracker('set', 'forceSSL', true);
		__gaTracker('send','pageview');
		__gaTracker( function() { window.ga = __gaTracker; } );
	} else {
		console.log( "" );
		(function() {
			/* https://developers.google.com/analytics/devguides/collection/analyticsjs/ */
			var noopfn = function() {
				return null;
			};
			var noopnullfn = function() {
				return null;
			};
			var Tracker = function() {
				return null;
			};
			var p = Tracker.prototype;
			p.get = noopfn;
			p.set = noopfn;
			p.send = noopfn;
			var __gaTracker = function() {
				var len = arguments.length;
				if ( len === 0 ) {
					return;
				}
				var f = arguments[len-1];
				if ( typeof f !== 'object' || f === null || typeof f.hitCallback !== 'function' ) {
					console.log( 'Not running function __gaTracker(' + arguments[0] + " ....) because you are not being tracked. " + em_no_track_reason );
					return;
				}
				try {
					f.hitCallback();
				} catch (ex) {

				}
			};
			__gaTracker.create = function() {
				return new Tracker();
			};
			__gaTracker.getByName = noopnullfn;
			__gaTracker.getAll = function() {
				return [];
			};
			__gaTracker.remove = noopfn;
			window['__gaTracker'] = __gaTracker;
			window.ga = __gaTracker;		})();
		}
</script>
<!-- / Google Analytics by ExactMetrics -->
		<script type="text/javascript">
			window._wpemojiSettings = {"baseUrl":"https:\/\/s.w.org\/images\/core\/emoji\/12.0.0-1\/72x72\/","ext":".png","svgUrl":"https:\/\/s.w.org\/images\/core\/emoji\/12.0.0-1\/svg\/","svgExt":".svg","source":{"concatemoji":"https:\/\/www.cebm.net\/wp-includes\/js\/wp-emoji-release.min.js?ver=017968d019780d65daeb52a762ad0f3c"}};
			!function(e,a,t){var r,n,o,i,p=a.createElement("canvas"),s=p.getContext&&p.getContext("2d");function c(e,t){var a=String.fromCharCode;s.clearRect(0,0,p.width,p.height),s.fillText(a.apply(this,e),0,0);var r=p.toDataURL();return s.clearRect(0,0,p.width,p.height),s.fillText(a.apply(this,t),0,0),r===p.toDataURL()}function l(e){if(!s||!s.fillText)return!1;switch(s.textBaseline="top",s.font="600 32px Arial",e){case"flag":return!c([127987,65039,8205,9895,65039],[127987,65039,8203,9895,65039])&&(!c([55356,56826,55356,56819],[55356,56826,8203,55356,56819])&&!c([55356,57332,56128,56423,56128,56418,56128,56421,56128,56430,56128,56423,56128,56447],[55356,57332,8203,56128,56423,8203,56128,56418,8203,56128,56421,8203,56128,56430,8203,56128,56423,8203,56128,56447]));case"emoji":return!c([55357,56424,55356,57342,8205,55358,56605,8205,55357,56424,55356,57340],[55357,56424,55356,57342,8203,55358,56605,8203,55357,56424,55356,57340])}return!1}function d(e){var t=a.createElement("script");t.src=e,t.defer=t.type="text/javascript",a.getElementsByTagName("head")[0].appendChild(t)}for(i=Array("flag","emoji"),t.supports={everything:!0,everythingExceptFlag:!0},o=0;o<i.length;o++)t.supports[i[o]]=l(i[o]),t.supports.everything=t.supports.everything&&t.supports[i[o]],"flag"!==i[o]&&(t.supports.everythingExceptFlag=t.supports.everythingExceptFlag&&t.supports[i[o]]);t.supports.everythingExceptFlag=t.supports.everythingExceptFlag&&!t.supports.flag,t.DOMReady=!1,t.readyCallback=function(){t.DOMReady=!0},t.supports.everything||(n=function(){t.readyCallback()},a.addEventListener?(a.addEventListener("DOMContentLoaded",n,!1),e.addEventListener("load",n,!1)):(e.attachEvent("onload",n),a.attachEvent("onreadystatechange",function(){"complete"===a.readyState&&t.readyCallback()})),(r=t.source||{}).concatemoji?d(r.concatemoji):r.wpemoji&&r.twemoji&&(d(r.twemoji),d(r.wpemoji)))}(window,document,window._wpemojiSettings);
		</script>
		<style type="text/css">
img.wp-smiley,
img.emoji {
	display: inline !important;
	border: none !important;
	box-shadow: none !important;
	height: 1em !important;
	width: 1em !important;
	margin: 0 .07em !important;
	vertical-align: -0.1em !important;
	background: none !important;
	padding: 0 !important;
}
</style>
	<link rel='stylesheet' id='yarppWidgetCss-css'  href='https://www.cebm.net/wp-content/plugins/yet-another-related-posts-plugin/style/widget.css?ver=017968d019780d65daeb52a762ad0f3c' type='text/css' media='all' />
<link rel='stylesheet' id='timeline_pro-css-css'  href='https://www.cebm.net/wp-content/plugins/timeline-pro/css/style.css?ver=017968d019780d65daeb52a762ad0f3c' type='text/css' media='all' />
<link rel='stylesheet' id='wp-color-picker-css'  href='https://www.cebm.net/wp-admin/css/color-picker.min.css?ver=017968d019780d65daeb52a762ad0f3c' type='text/css' media='all' />
<link rel='stylesheet' id='social-warfare-block-css-css'  href='https://www.cebm.net/wp-content/plugins/social-warfare/assets/js/post-editor/dist/blocks.style.build.css?ver=017968d019780d65daeb52a762ad0f3c' type='text/css' media='all' />
<link rel='stylesheet' id='addtofeedly-style-css'  href='https://www.cebm.net/wp-content/plugins/add-to-feedly/style.css?ver=017968d019780d65daeb52a762ad0f3c' type='text/css' media='all' />
<link rel='stylesheet' id='css-toolpop-css'  href='https://www.cebm.net/wp-content/plugins/get-it-glossary/assets/css/jquery.toolpop.css?ver=017968d019780d65daeb52a762ad0f3c' type='text/css' media='all' />
<link rel='stylesheet' id='subscribe-and-connect-css'  href='https://www.cebm.net/wp-content/plugins/subscribe-and-connect/assets/css/frontend.css?ver=1.1.4' type='text/css' media='all' />
<link rel='stylesheet' id='social_warfare-css'  href='https://www.cebm.net/wp-content/plugins/social-warfare/assets/css/style.min.css?ver=3.6.1' type='text/css' media='all' />
<link rel='stylesheet' id='wp-conversion-boxes-plugin-styles-css'  href='https://www.cebm.net/wp-content/plugins/wp-conversion-boxes/public/assets/css/public.css?ver=017968d019780d65daeb52a762ad0f3c' type='text/css' media='all' />
<link rel='stylesheet' id='twentytwelve-fonts-css'  href='https://fonts.googleapis.com/css?family=Open+Sans:400italic,700italic,400,700&#038;subset=latin,latin-ext' type='text/css' media='all' />
<link rel='stylesheet' id='simcal-qtip-css'  href='https://www.cebm.net/wp-content/plugins/google-calendar-events/assets/css/vendor/jquery.qtip.min.css?ver=3.1.22' type='text/css' media='all' />
<link rel='stylesheet' id='simcal-default-calendar-grid-css'  href='https://www.cebm.net/wp-content/plugins/google-calendar-events/assets/css/default-calendar-grid.min.css?ver=3.1.22' type='text/css' media='all' />
<link rel='stylesheet' id='simcal-default-calendar-list-css'  href='https://www.cebm.net/wp-content/plugins/google-calendar-events/assets/css/default-calendar-list.min.css?ver=3.1.22' type='text/css' media='all' />
<link rel='stylesheet' id='wpgdprc.css-css'  href='https://www.cebm.net/wp-content/plugins/wp-gdpr-compliance/assets/css/front.css?ver=1559664997' type='text/css' media='all' />
<style id='wpgdprc.css-inline-css' type='text/css'>

            div.wpgdprc .wpgdprc-switch .wpgdprc-switch-inner:before { content: 'Yes'; }
            div.wpgdprc .wpgdprc-switch .wpgdprc-switch-inner:after { content: 'No'; }
        
</style>
<link rel='stylesheet' id='wp-author-bio-css'  href='https://www.cebm.net/wp-content/plugins/wp-about-author/wp-about-author.css?ver=017968d019780d65daeb52a762ad0f3c' type='text/css' media='all' />
<script type='text/javascript' src='https://www.cebm.net/wp-includes/js/jquery/jquery.js?ver=1.12.4-wp'></script>
<script type='text/javascript' src='https://www.cebm.net/wp-includes/js/jquery/jquery-migrate.min.js?ver=1.4.1'></script>
<script type='text/javascript'>
/* <![CDATA[ */
var timeline_pro_ajax = {"timeline_pro_ajaxurl":"https:\/\/www.cebm.net\/wp-admin\/admin-ajax.php"};
/* ]]> */
</script>
<script type='text/javascript' src='https://www.cebm.net/wp-content/plugins/timeline-pro/js/timeline-pro-script.js?ver=017968d019780d65daeb52a762ad0f3c'></script>
<script type='text/javascript'>
/* <![CDATA[ */
var exactmetrics_frontend = {"js_events_tracking":"true","download_extensions":"zip,mp3,mpeg,pdf,docx,pptx,xlsx,rar","inbound_paths":"[{\"path\":\"\\\/go\\\/\",\"label\":\"affiliate\"},{\"path\":\"\\\/recommend\\\/\",\"label\":\"affiliate\"}]","home_url":"https:\/\/www.cebm.net","hash_tracking":"false"};
/* ]]> */
</script>
<script type='text/javascript' src='https://www.cebm.net/wp-content/plugins/google-analytics-dashboard-for-wp/assets/js/frontend.min.js?ver=6.0.2'></script>
<script type='text/javascript' src='https://www.cebm.net/wp-content/plugins/add-to-feedly/js/jquery-1.10.2.min.js?ver=017968d019780d65daeb52a762ad0f3c'></script>
<script type='text/javascript' src='https://www.cebm.net/wp-content/plugins/add-to-feedly/js/scripts.js?ver=017968d019780d65daeb52a762ad0f3c'></script>
<script type='text/javascript' src='https://www.cebm.net/wp-content/plugins/get-it-glossary/assets/js/jquery.toolpop.js?ver=017968d019780d65daeb52a762ad0f3c'></script>
<script type='text/javascript'>
/* <![CDATA[ */
var trackerDefaultData = {"ajaxurl":"https:\/\/www.cebm.net\/wp-admin\/admin-ajax.php","nonce":"0a2dce4c8c","processingHead":"Processing... Please Wait!","processingBody":"It's taking longer than usual. Please hang on for a few moments...","successHead":"Success!","successBody":"Thank you for subscribing.","errorHead":"Error!","errorBody":"There was an error submitting your info."};
/* ]]> */
</script>
<script type='text/javascript' src='https://www.cebm.net/wp-content/plugins/wp-conversion-boxes/public/assets//js/tracker.js?ver=017968d019780d65daeb52a762ad0f3c'></script>
<script type='text/javascript' src='https://www.cebm.net/wp-content/plugins/wp-conversion-boxes/public/assets//js/jquery.visible.min.js?ver=017968d019780d65daeb52a762ad0f3c'></script>
<link rel='https://api.w.org/' href='https://www.cebm.net/wp-json/' />
<link rel="EditURI" type="application/rsd+xml" title="RSD" href="https://www.cebm.net/xmlrpc.php?rsd" />
<link rel="wlwmanifest" type="application/wlwmanifest+xml" href="https://www.cebm.net/wp-includes/wlwmanifest.xml" /> 

<link rel='shortlink' href='https://www.cebm.net/?p=14134' />
<link rel="alternate" type="application/json+oembed" href="https://www.cebm.net/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fwww.cebm.net%2Foxford-covid-19%2Fcovid-19-registered-trials-and-analysis%2F" />
<link rel="alternate" type="text/xml+oembed" href="https://www.cebm.net/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fwww.cebm.net%2Foxford-covid-19%2Fcovid-19-registered-trials-and-analysis%2F&#038;format=xml" />

<style>
/* GET-IT GLOSSARY */
  
 #getit_subtitle {
  font-size: small;
  margin-top: -20px;
  margin-bottom: 10px;
}

li.widget_getit_widget {
background: #EAE9E9;
}

#getit_definition {
    background: #EAE9E9;
    padding: 20px;
}

#getit_definition h2 {
font-size: 20px;
line-height: 24px;
color: #731744;
}
#getit_definition strong {
  color: #731744;
}

#getit_terms {
    width: 90%;
    margin: 20px auto 0;
display: block;
    font-size: 18px !important;
}

#getit_subtitle {
margin-top: -10px; display:block;
}
</style><script type="text/javascript" src="//script.crazyegg.com/pages/scripts/0080/5806.js" async="async"></script><style type="text/css">.broken_link, a.broken_link {
	text-decoration: line-through;
}</style><link rel="icon" href="https://www.cebm.net/wp-content/uploads/2014/04/CEBM-store-150x150.png" sizes="32x32" />
<link rel="icon" href="https://www.cebm.net/wp-content/uploads/2014/04/CEBM-store.png" sizes="192x192" />
<link rel="apple-touch-icon-precomposed" href="https://www.cebm.net/wp-content/uploads/2014/04/CEBM-store.png" />
<meta name="msapplication-TileImage" content="https://www.cebm.net/wp-content/uploads/2014/04/CEBM-store.png" />
<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-51854186-1', 'cebm.net');
  ga('send', 'pageview');

</script>
</head>
<body class="page-template-default page page-id-14134 page-child parent-pageid-14081 custom-background-empty custom-font-enabled">
<header><div class="header-content">
    <div class="container"> 
        <div class="oxford-uni one-third column">
            <img src="https://www.cebm.net/wp-content/themes/cebm-redux/images/oxford-uni-logo-cebm.png" alt="CEBM and Oxford University Logos" />
        </div>

        <div class="logo two-thirds column">
            <h1>CEBM</h1>
            <p style="margin: 120px 0 0 5px;"><small>The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare.</small></p>
        </div>
           </div>
</div>
</header>
<div id="mainMenu">
<nav class="main"   >
<div class="container">
    <div class="mobile-nav">Navigate this website</div>
    <div class="main twelve columns"> 
        <div class="menu-navigation-container"><ul id="menu-navigation" class="menu"><li id="menu-item-32" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-home menu-item-32"><a href="https://www.cebm.net/">Home</a></li>
<li id="menu-item-11647" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-11647"><a title="Oxford School of Evidence-Based Health Care" href="https://www.cebm.net/study-with-us/">School of EBHC</a></li>
<li id="menu-item-11623" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-has-children menu-item-11623"><a href="https://www.cebm.net/category/blog/">Blog</a>
<ul class="sub-menu">
	<li id="menu-item-12033" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-12033"><a href="https://www.cebm.net/podcasts/">CEBM Podcasts</a></li>
	<li id="menu-item-12349" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-12349"><a href="https://www.cebm.net/bmj-talk-evidence-podcast/">BMJ Talk Evidence Podcast</a></li>
</ul>
</li>
<li id="menu-item-10327" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-10327"><a href="https://www.cebm.net/resources-2/">Resources</a>
<ul class="sub-menu">
	<li id="menu-item-7729" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-7729"><a href="https://www.cebm.net/category/ebm-resources/cebmtalks/">Talks &#038; Presentations</a></li>
	<li id="menu-item-72" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-has-children menu-item-72"><a title="Evidence-Based Medicine Tools" href="https://www.cebm.net/category/ebm-resources/tools/">EBM Tools</a>
	<ul class="sub-menu">
		<li id="menu-item-5598" class="menu-item menu-item-type-post_type menu-item-object-post menu-item-5598"><a href="https://www.cebm.net/2016/02/everything-for-a-diy-1-day-workshop/">DIY EBM Workshop</a></li>
		<li id="menu-item-74" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-74"><a href="https://www.cebm.net/category/ebm-resources/tools/asking-focused-questions/">Asking Focused Questions</a></li>
		<li id="menu-item-73" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-73"><a href="https://www.cebm.net/category/ebm-resources/tools/finding-the-evidence/">Finding Evidence</a></li>
		<li id="menu-item-75" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-75"><a href="https://www.cebm.net/category/ebm-resources/tools/critically-appraising-the-evidence/">Critical Appraisal</a></li>
		<li id="menu-item-135" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-135"><a href="https://www.cebm.net/category/ebm-resources/tools/making-a-decision/">Making a Decision</a></li>
		<li id="menu-item-136" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-136"><a href="https://www.cebm.net/category/ebm-resources/tools/designing-research/">Designing Research</a></li>
	</ul>
</li>
	<li id="menu-item-5630" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5630"><a href="https://www.cebm.net/category/ebm-resources/loe/">Levels of Evidence</a></li>
	<li id="menu-item-162" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-162"><a href="https://www.cebm.net/ebm-library/">EBM Library</a></li>
	<li id="menu-item-11547" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-11547"><a href="https://www.youtube.com/channel/UCier2CaQeEuW1JOBn67ECjg">YouTube Channel</a></li>
</ul>
</li>
<li id="menu-item-10292" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-10292"><a href="https://www.cebm.net/cebm-research/">Research</a>
<ul class="sub-menu">
	<li id="menu-item-5786" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5786"><a href="https://www.cebm.net/category/big-data/">Methods &#038; Data</a></li>
	<li id="menu-item-531" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-531"><a href="https://www.cebm.net/category/communicating-evidence/">Communication</a></li>
	<li id="menu-item-528" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-528"><a href="https://www.cebm.net/category/diagnostics/">Diagnostics</a></li>
	<li id="menu-item-10317" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-10317"><a href="https://www.cebm.net/category/health-services/">Health Services</a></li>
	<li id="menu-item-532" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-532"><a href="https://www.cebm.net/category/prevention/">Prevention</a></li>
	<li id="menu-item-2726" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-2726"><a href="https://www.cebm.net/category/therapeutics/">Therapeutics</a></li>
	<li id="menu-item-12429" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-12429"><a href="https://www.cebm.net/category/cebm-protocols/">Protocols</a></li>
	<li id="menu-item-12663" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-12663"><a href="https://www.cebm.net/category/cebm-reports/">Reports</a></li>
</ul>
</li>
<li id="menu-item-12981" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-12981"><a href="https://www.cebm.net/category/impacts/">Impacts</a></li>
<li id="menu-item-10296" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-10296"><a href="https://www.cebm.net/outreach/">Outreach</a>
<ul class="sub-menu">
	<li id="menu-item-8509" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-8509"><a href="https://www.cebm.net/category/public-engagement/">Public Engagement</a></li>
	<li id="menu-item-12096" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-12096"><a href="https://www.cebm.net/ebm-in-schools/">EBM in Schools</a></li>
	<li id="menu-item-10144" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-10144"><a href="/events/">Events</a></li>
</ul>
</li>
</ul></div>    </div>
    <div class="search four columns"> 
        <form action="/" method="get">
    <input type="search" class="search-input" placeholder="Search" value="" name="s" id="search" /><input type="submit" class="search-submit" value="submit" />
</form>    </div>
</nav>
<nav class="second_level" id="subMenu">
  <div class="container">
    <div class="sixteen columns">
      <div class="menu-navigation-container"><ul id="menu-navigation-1" class="menu"><li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-home menu-item-32"><a href="https://www.cebm.net/">Home</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-11647"><a title="Oxford School of Evidence-Based Health Care" href="https://www.cebm.net/study-with-us/">School of EBHC</a></li>
<li class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-has-children menu-item-11623"><a href="https://www.cebm.net/category/blog/">Blog</a>
<ul class="sub-menu">
	<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-12033"><a href="https://www.cebm.net/podcasts/">CEBM Podcasts</a></li>
	<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-12349"><a href="https://www.cebm.net/bmj-talk-evidence-podcast/">BMJ Talk Evidence Podcast</a></li>
</ul>
</li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-10327"><a href="https://www.cebm.net/resources-2/">Resources</a>
<ul class="sub-menu">
	<li class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-7729"><a href="https://www.cebm.net/category/ebm-resources/cebmtalks/">Talks &#038; Presentations</a></li>
	<li class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-has-children menu-item-72"><a title="Evidence-Based Medicine Tools" href="https://www.cebm.net/category/ebm-resources/tools/">EBM Tools</a></li>
	<li class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5630"><a href="https://www.cebm.net/category/ebm-resources/loe/">Levels of Evidence</a></li>
	<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-162"><a href="https://www.cebm.net/ebm-library/">EBM Library</a></li>
	<li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-11547"><a href="https://www.youtube.com/channel/UCier2CaQeEuW1JOBn67ECjg">YouTube Channel</a></li>
</ul>
</li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-10292"><a href="https://www.cebm.net/cebm-research/">Research</a>
<ul class="sub-menu">
	<li class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5786"><a href="https://www.cebm.net/category/big-data/">Methods &#038; Data</a></li>
	<li class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-531"><a href="https://www.cebm.net/category/communicating-evidence/">Communication</a></li>
	<li class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-528"><a href="https://www.cebm.net/category/diagnostics/">Diagnostics</a></li>
	<li class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-10317"><a href="https://www.cebm.net/category/health-services/">Health Services</a></li>
	<li class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-532"><a href="https://www.cebm.net/category/prevention/">Prevention</a></li>
	<li class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-2726"><a href="https://www.cebm.net/category/therapeutics/">Therapeutics</a></li>
	<li class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-12429"><a href="https://www.cebm.net/category/cebm-protocols/">Protocols</a></li>
	<li class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-12663"><a href="https://www.cebm.net/category/cebm-reports/">Reports</a></li>
</ul>
</li>
<li class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-12981"><a href="https://www.cebm.net/category/impacts/">Impacts</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-10296"><a href="https://www.cebm.net/outreach/">Outreach</a>
<ul class="sub-menu">
	<li class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-8509"><a href="https://www.cebm.net/category/public-engagement/">Public Engagement</a></li>
	<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-12096"><a href="https://www.cebm.net/ebm-in-schools/">EBM in Schools</a></li>
	<li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-10144"><a href="/events/">Events</a></li>
</ul>
</li>
</ul></div>    </div>
  </div>
</nav>
</div><section class="bg-grey">
<div class="container">
	<div class="content twelve columns">
				<h1>COVID-19 Registered Trials &#8211; and analysis</h1>
	
      		<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html><head><script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script></head><body><p><strong>COVID-19 trials registered up to 8 March 2020&mdash;an analysis of 382 studies</strong></p>
<p style="text-align: right;">Jeff Aronson, Robin Ferner, Nicholas DeVito, Carl Heneghan</p>
<p style="text-align: right;">Download <a href="https://www.cebm.net/wp-content/uploads/2020/03/COVID-19-registered-trials%E2%80%94an-analysis-1.pdf">COVID-19 registered trials&mdash;an analysis (1)</a></p>
<hr>
<p>On 31 December 2019, China reported cases of pneumonia from a previously unknown coronavirus, 2019-nCoV, also called SARS-CoV-2.&nbsp; The disease it causes has been called COVID-19. The<a href="https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6"> latest figures</a> (17 March 2020) suggest that about 180,00 people have been infected worldwide, with about 7200 deaths. The World Health Organization (WHO) designated COVID-19 a &ldquo;public health emergency of international concern&rdquo; on 30 January and declared it a pandemic on 11 March.</p>
<p>COVID-19 should have come as no surprise. Gralinski and Baric, in a <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4797993/">review</a> in 2015 wrote: &ldquo;The existence of novel bat SARS-like coronaviruses that also use bat, civet and human angiotensin 1 converting enzyme 2 (ACE2) receptors for entry, such as SARS-CoV [now SARS-CoV-1], strongly suggests an opportunity for further zoonotic disease outbreaks in human and animal populations.&rdquo; Yet attempts to develop effective treatments against two other coronavirus diseases, SARS and MERS, have so far <a href="https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0030343">failed</a>.</p>
<p>The coronaviruses are single-stranded RNA viruses that encode for four enzymes essential to the viral life cycle. They enter mammalian cells through an interaction of a viral spike glycoprotein and a receptor&mdash;ACE2 for SARS-CoV-1 and SARS-CoV-2 and dipetidylpeptidase 4 for MERS.</p>
<p>While the outbreak of COVID-19 was intensifying and spreading globally, 382 trials were registered between 23 January and 8 March (379 registered in China) on the WHO&rsquo;s International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/AdvSearch.aspx?SearchTermStat=117&amp;ReturnUrl=~/ListBy.aspx?TypeListing=0">ICTRP</a>), some of which might affect morbidity and mortality and help us understand the disease.</p>
<p>We downloaded the listings of these 382 registered trials and classified them to aid interpretation of the type of interventions being proposed. The numbers of new trials that have been added to the list since the middle of&nbsp; January are shown in Figure 1.</p>
<p><a href="https://www.cebm.net/wp-content/uploads/2020/03/Registered-trials.png"><img class="size-full wp-image-14336 aligncenter" src="https://www.cebm.net/wp-content/uploads/2020/03/Registered-trials.png" alt="" width="1200" height="600" srcset="https://www.cebm.net/wp-content/uploads/2020/03/Registered-trials.png 1200w, https://www.cebm.net/wp-content/uploads/2020/03/Registered-trials-300x150.png 300w, https://www.cebm.net/wp-content/uploads/2020/03/Registered-trials-1024x512.png 1024w, https://www.cebm.net/wp-content/uploads/2020/03/Registered-trials-768x384.png 768w" sizes="(max-width: 1200px) 100vw, 1200px"></a></p>
<p><strong>Figure 1.</strong> The numbers of new trials added to the WHO&rsquo;s website week by week (blue), with the cumulative numbers (orange)</p>
<p>We categorized the 382 registered trials as follows (Figure 2):</p>
<ul>
<li><strong>Pharmacological interventions, n = 108</strong>; see Table 1.</li>
<li><strong>Traditional Chinese Medicine (TCM), n = 98</strong> (includes 48 named TCMs; 27 unspecified methods; 18 combinations with unspecified Western therapies; and 5 others, e.g. acupuncture).</li>
<li><strong>Clinical presentation, n = 81 </strong>(includes 63 studies of epidemiology, susceptibility factors, and clinical outcomes; 21 studies of diagnostic methods, both clinical and laboratory; and 19studies of prognostic features).</li>
<li><a href="https://www.gov.uk/guidance/advanced-therapy-medicinal-products-regulation-and-licensing#overview"><strong>Advanced therapy medicinal products (ATMP</strong></a><a href="https://www.gov.uk/guidance/advanced-therapy-medicinal-products-regulation-and-licensing#overview">),</a> <strong>n = 38</strong>, are medicinal products that include cellular therapies, tissue extracts, plasma, and vaccines for treatment not prevention. See the box at the end of the article for the 24 different interventions under investigation, the most common being mesenchymal stem cells and infusion of plasma from patients who have recovered (5 registered trials each).</li>
<li><strong>Others,</strong> <strong>n =</strong> <strong>33 </strong>(includes nutritional supplements and enteral feeds; physiotherapy and exercise; physical therapies, such as renal replacement therapy; and psychotherapies).</li>
<li>Two registered trials have been cancelled.</li>
</ul>
<p><img class="wp-image-14200 aligncenter" src="https://www.cebm.net/wp-content/uploads/2020/03/trials-tracker-2.png" alt="" width="751" height="365" srcset="https://www.cebm.net/wp-content/uploads/2020/03/trials-tracker-2.png 1200w, https://www.cebm.net/wp-content/uploads/2020/03/trials-tracker-2-300x146.png 300w, https://www.cebm.net/wp-content/uploads/2020/03/trials-tracker-2-1024x497.png 1024w, https://www.cebm.net/wp-content/uploads/2020/03/trials-tracker-2-768x373.png 768w, https://www.cebm.net/wp-content/uploads/2020/03/trials-tracker-2-410x200.png 410w" sizes="(max-width: 751px) 100vw, 751px"></p>
<p>&nbsp;</p>
<p><strong>Proposed pharmacological interventions</strong></p>
<p><a href="https://media.nature.com/original/magazine-assets/d41573-020-00016-0/17663286" target="_blank" rel="noopener noreferrer">Several agents may act directly against coronaviruses</a>. Others, particularly monoclonal antibodies,&nbsp; may limit the cytokine dysregulation that causes fatal respiratory disease. Others may provide symptomatic relief.</p>
<p>In Table 1 we have listed the proposed pharmacological interventions and their mechanisms, when known, classified under 10 main headings (plus one heading to deal with combination studies):</p>
<ul>
<li>Antiviral drugs, not specified</li>
<li>Antiviral drugs, broad spectrum</li>
<li>Antiviral drugs, antiretrovirals</li>
<li>Other antiviral drugs</li>
<li>Antimalarial drugs</li>
<li>Antibiotics and antiparasitics</li>
<li>Nonspecific anti-inflammatory and immunosuppressive drugs</li>
<li>Kinase inhibitors</li>
<li>Monoclonal antibodies</li>
<li>Miscellaneous others</li>
</ul>
<p>Antiviral drugs that affect other RNA viruses (which include Ebola virus, rabies, influenza, hepatitis C, West Nile fever, polio, and measles), some of which have also been shown to have in vitro activity against 2019-nCoV, might be effective in COVID-19. However, in vitro activity of this sort does not guarantee clinical efficacy. Indeed, a note of caution is required. In experimental animals <a href="https://www.ncbi.nlm.nih.gov/pubmed/16621037">ribavirin</a>, for example, enhanced the infectivity of SARS-CoV-1. Furthermore, in a <a href="https://www.ncbi.nlm.nih.gov/pubmed/16968120">systematic review</a> of 30 trials of ribavirin in patients with SARS, 26 were classified as inconclusive and four showed possible harm. There is no guarantee that antiviral drugs will be beneficial in COVID-19, and adverse reactions are likely.</p>
<p>Antiviral drugs that are effective against DNA viruses, such as HIV, would not be expected to be as efficacious. Although some have been shown to be effective in vitro against 2019-nCoV, that is no guarantee of in vivo efficacy.</p>
<p>Chloroquine has been shown to be effective, both in vitro and clinically, against the coronavirus that caused SARS in 2003-4, SARS-CoV-1. Again, this does not predict clinical efficacy in COVID-19.</p>
<p>Corticosteroids may be harmful. In a <a href="https://www.ncbi.nlm.nih.gov/pubmed/16968120">systematic review of 29 low-quality studies</a> of steroid use, 25 were inconclusive and in four there was evidence of harm.&nbsp; A further <a href="https://www.ncbi.nlm.nih.gov/pubmed/32043983">evidence review</a> did not support corticosteroid treatment, reporting no evidence of net benefit with corticosteroids in &ldquo;respiratory infection due to RSV, influenza, SARS-CoV [SARS-CoV-1], or MERS-CoV&rdquo;, and showing that corticosteroids probably impair clearance of SARS-CoV-1.</p>
<p>As far as the miscellaneous group of other medicines is concerned, there are mechanistic arguments in favour of some of them and not others. For example, there is no good evidence that vitamin C is efficacious in treating any condition other than vitamin C deficiency; furthermore, the <a href="https://pubmed.ncbi.nlm.nih.gov/11135611">pharmacokinetics</a> of vitamin C are such that the administration of even very high oral doses does not increase the body load, as reflected by plasma concentrations, by more than twofold and can cause diarrhoea and renal stones, since its absorption from the gut is saturable and it has high renal clearance.</p>
<p><strong>Table 1.</strong> <em>Medicines that are currently undergoing clini</em><em>cal trials or have trials planned in the management of COVID-19, due to the single-stranded RNA virus 2109-nCoV (SARS-CoV-2)</em></p>
<p>&nbsp;</p>
<table style="width: 94.1417%;" width="0">
<tbody>
<tr>
<td style="width: 24.2574%;" width="122"><strong>&nbsp;</strong>
<p><strong>Type of medicine</strong></p></td>
<td style="width: 67.4607%;" width="374"><strong>&nbsp;</strong>
<p><strong>Mechanism of action</strong></p></td>
<td style="width: 91.4667%;" width="71"><strong>No. of trials</strong></td>
</tr>
<tr>
<td style="width: 183.185%;" colspan="3" width="567"><strong><em>Antiviral drugs, non-specific </em></strong></td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Immunoglobulin</td>
<td style="width: 67.4607%;" width="374">Contains nonspecific antibodies; <a href="https://pubmed.ncbi.nlm.nih.gov/32125642">proposed</a> to block viral Fc receptor activation by boosting endogenous neutralizing antibodies and preventing antibody-dependent enhancement of infection</td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Interferons</td>
<td style="width: 67.4607%;" width="374">Activate cytoplasmic enzymes affecting viral messenger RNA translation and protein synthesis; <a href="https://www.ncbi.nlm.nih.gov/pubmed/25278221">evidence</a> of minor efficacy in MERS-CoV in combination with ribavirin</td>
<td style="width: 91.4667%;" width="71">4</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Interleukin-2</td>
<td style="width: 67.4607%;" width="374">Multiple anti-inflammatory actions</td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 91.7181%;" colspan="2" width="496"><strong><em>Antiviral drugs, broad spectrum</em></strong></td>
<td style="width: 91.4667%;" width="71"><strong><em>&nbsp;</em></strong></td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Favipiravir</td>
<td style="width: 67.4607%;" width="374">Inhibitor of viral RNA-dependent RNA polymerase; typically used in treating influenza, but <a href="https://pubmed.ncbi.nlm.nih.gov/?term=New+nucleoside+analogues+for+the+treatment+of+hemorrhagic+fever+virus+infections">inhibits</a> the polymerase of other viruses in vitro (Ebola, yellow fever, chikungunya, norovirus, and <a href="https://pubmed.ncbi.nlm.nih.gov/32020029">2019-nCoV</a>)</td>
<td style="width: 91.4667%;" width="71">4</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Triazavirin</td>
<td style="width: 67.4607%;" width="374">Non-nucleoside antiviral drug; effective against tick-borne encephalitis virus and forest-spring encephalitis virus</td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Umifenovir</td>
<td style="width: 67.4607%;" width="374">Membrane haemagglutinin fusion <a href="https://www.ncbi.nlm.nih.gov/pubmed/28003465">inhibitor</a> in influenza viruses; active against influenza virus infections, in which it may <a href="https://www.ncbi.nlm.nih.gov/pubmed/30974127">reduce the risk</a> of bacterial pneumonia</td>
<td style="width: 91.4667%;" width="71">5</td>
</tr>
<tr>
<td style="width: 91.7181%;" colspan="2" width="496"><strong><em>Antiviral drugs, antiretrovirals</em></strong></td>
<td style="width: 91.4667%;" width="71"></td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">ASC09</td>
<td style="width: 67.4607%;" width="374">HIV protease <a href="https://media.nature.com/original/magazine-assets/d41573-020-00016-0/17663286">inhibitor</a>; to be used in combination with ritonavir</td>
<td style="width: 91.4667%;" width="71">4</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Azvudine</td>
<td style="width: 67.4607%;" width="374"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140803/">Azidocytidine</a><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140803/"> nucleoside analogue</a>; HIV reverse transcriptase inhibitor</td>
<td style="width: 91.4667%;" width="71">4</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Danoprevir</td>
<td style="width: 67.4607%;" width="374">Hepatitis C virus NS3 protease <a href="https://www.ncbi.nlm.nih.gov/pubmed/30117020">inhibitor</a>; to be used in combination with ritonavir</td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Darunavir</td>
<td style="width: 67.4607%;" width="374">HIV protease inhibitor; used in combination with <a href="https://www.ncbi.nlm.nih.gov/pubmed/31933482">cobicistat</a>, a CYP3A inhibitor</td>
<td style="width: 91.4667%;" width="71">2</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Lopinavir + ritonavir</td>
<td style="width: 67.4607%;" width="374">Both HIV reverse transcriptase inhibitors; ritonavir is mainly used to enhance the action of other drugs by inhibition of CYP3A4; in vitro and possible clinical <a href="https://www.ncbi.nlm.nih.gov/pubmed/14985565">efficacy</a> in SARS-CoV</td>
<td style="width: 91.4667%;" width="71">2</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Remdesivir</td>
<td style="width: 67.4607%;" width="374">Nucleotide analogue; inhibitor of RNA-dependent RNA polymerase; used to treat Ebola and Marburg viruses; <a href="https://www.ncbi.nlm.nih.gov/pubmed/28659436">effective</a> in vitro against SARS-CoV-1 and MERS and <a href="https://www.ncbi.nlm.nih.gov/pubmed/32020029">blocks infection</a> with 2019-nCoV in vitro</td>
<td style="width: 91.4667%;" width="71">2</td>
</tr>
<tr>
<td style="width: 183.185%;" colspan="3" width="567"><strong><em>Other antiviral drugs</em></strong></td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Baloxavir marboxil</td>
<td style="width: 67.4607%;" width="374"><a href="https://www.ncbi.nlm.nih.gov/pubmed/30476172">Inhibitor</a> of influenza virus cap-dependent endonuclease; to be combined with favipiravir or lopinavir/ritonavir</td>
<td style="width: 91.4667%;" width="71">2</td>
</tr>
<tr>
<td style="width: 183.185%;" colspan="3" width="567"><strong><em>Antimalarial drugs</em></strong></td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Chloroquine and hydroxychloroquine</td>
<td style="width: 67.4607%;" width="374">In addition to its antimalarial actions, chloroquine has some efficacy in HIV-AIDS and <a href="https://www.ncbi.nlm.nih.gov/pubmed/32020029">blocks infection</a> by 2019-nCoV in vitro, <a href="https://pubmed.ncbi.nlm.nih.gov/16439323">perhaps</a> by inhibiting glycosylation of viral ACE-2 or inhibition of quinone reductase 2, reducing synthesis of viral sialic acid; in one study to be combined with lopinavir/ritonavir</td>
<td style="width: 91.4667%;" width="71">23</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Dihydroartemisinin</td>
<td style="width: 67.4607%;" width="374">Interaction between its peroxide bridge and haem iron may underlie its <a href="https://pubmed.ncbi.nlm.nih.gov/8891104">antimalarial action</a>; mechanisms of action against viruses, eg. <a href="https://pubmed.ncbi.nlm.nih.gov/30801742">zika virus</a>, are not well understood; to be combined with the antimalarial drug piperaquine</td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 183.185%;" colspan="3" width="567"><strong><em>Antibiotics and antiparasitics</em></strong></td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Carriomycin</td>
<td style="width: 67.4607%;" width="374">A polyether antibiotic; monovalent cation selective <a href="https://pubmed.ncbi.nlm.nih.gov/690008">ionophore</a>; active against Gram-positive bacteria, mycoplasma; fungi, and yeasts</td>
<td style="width: 91.4667%;" width="71">2</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Suramin sodium</td>
<td style="width: 67.4607%;" width="374">Antiparasitic; <a href="https://pubmed.ncbi.nlm.nih.gov/31667504">mode of action</a> not known; used to treat first-stage African trypanosomiasis and onchocerciasis</td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 183.185%;" colspan="3" width="567"><strong><em>Nonspecific anti-inflammatory and immunosuppressive drugs</em></strong></td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Corticosteroids</td>
<td style="width: 67.4607%;" width="374">Many anti-inflammatory actions; experience with corticosteroids in other infectious diseases has not been uniformly beneficial; in SARS corticosteroids may <a href="https://www.ncbi.nlm.nih.gov/pubmed/16968120">worsen the disease</a></td>
<td style="width: 91.4667%;" width="71">6</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Fingolimod</td>
<td style="width: 67.4607%;" width="374">Immunosuppressant; <a href="https://www.ncbi.nlm.nih.gov/pubmed/31523357">sphingosine 1-phosphate receptor modulator</a>; used in multiple sclerosis</td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Leflunomide</td>
<td style="width: 67.4607%;" width="374">Immunosuppressant; thalidomide analogue; <a href="https://www.ncbi.nlm.nih.gov/pubmed/9666414">inhibitor</a> of dihydro-orotate dehydrogenase and tyrosine kinases; causes <a href="https://www.ncbi.nlm.nih.gov/pubmed/31200856">degradation</a> of intracellular transcription factors; used to treat rheumatoid arthritis and psoriatic arthritis</td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Thalidomide</td>
<td style="width: 67.4607%;" width="374">Immunosuppressant; mode of action poorly understood; <a href="https://www.ncbi.nlm.nih.gov/pubmed/8861747">inhibits</a> production of excess tumour necrosis factor-alfa (TNF-&alpha;), down-regulates cell surface adhesion molecules involved in leukocyte migration, has <a href="https://www.ncbi.nlm.nih.gov/pubmed/26196302">anti-angiogenic</a> activity, and <a href="https://www.ncbi.nlm.nih.gov/pubmed/30694856">modulates</a> the thalidomide-binding protein, cereblon, <a href="https://www.ncbi.nlm.nih.gov/pubmed/31200856">mediating protein degradation</a>; used to treat multiple myeloma</td>
<td style="width: 91.4667%;" width="71">2</td>
</tr>
<tr>
<td style="width: 183.185%;" colspan="3" width="567"><strong><em>Kinase inhibitors</em></strong></td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Jakotinib hydrochloride</td>
<td style="width: 67.4607%;" width="374">[Chinese literature only]; presumed inhibitor of Janus-associated kinases</td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Ruxolitinib</td>
<td style="width: 67.4607%;" width="374">Inhibitor of Janus-associated kinases (JAK1 and JAK2); used to treat myelofibrosis, polycythaemia vera, and <a href="https://www.tandfonline.com/doi/full/10.1080/1744666X.2020.1740592">graft-versus-host disease</a>; to be combined with mesenchymal stem cell infusion</td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 91.7181%;" colspan="2" width="496"><strong><em>Monoclonal antibodies; to be used in combination with protease inhibitors</em></strong></td>
<td style="width: 91.4667%;" width="71">2</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Adalimumab</td>
<td style="width: 67.4607%;" width="374">Target: TNF-alfa; used to treat rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis, hidradenitis suppurativa, Crohn&rsquo;s disease, ulcerative colitis, and uveitis</td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Camrelizumab</td>
<td style="width: 67.4607%;" width="374"><a href="http://ncbi.nlm.nih.gov/pubmed/31313098">Target</a>: receptors for programmed cell death protein 1 (PD-1); used in China to treat Hodgkin&rsquo;s lymphoma and nasopharyngeal carcinoma, alone or in combination with gemcitabine + cisplatin</td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Eculizumab</td>
<td style="width: 67.4607%;" width="374"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584251/">Target</a>: C5 complement; used to treat paroxysmal nocturnal haemoglobinuria, atypical haemolytic uremic syndrome, refractory generalized myasthenia gravis, and neuromyelitis optica spectrum disorder</td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Mepolizumab</td>
<td style="width: 67.4607%;" width="374">Target: interleukin-5 (IL-5); used to treat <a href="https://www.nejm.org/doi/pdf/10.1056/NEJMoa1403290?articleTools=true">eosinophilic asthma</a></td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">PD-1 mAb</td>
<td style="width: 67.4607%;" width="374">Target: receptors for programmed cell death protein 1 (PD-1)</td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Tocilizumab</td>
<td style="width: 67.4607%;" width="374">Target: soluble and membrane-bound <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274717/">IL-6 receptors </a>(sIL-6R and mIL-6R); used to treat <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736769/pdf/40265_2017_Article_829.pdf">rheumatoid arthriti</a>s, systemic juvenile idiopathic arthritis, juvenile idiopathic polyarthritis, <a href="https://www.nejm.org/doi/pdf/10.1056/NEJMoa1613849?articleTools=true">giant -cell arteritis</a>, and chimeric antigen receptor (CAR) T cell-induced severe or life-threatening cytokine release syndrome</td>
<td style="width: 91.4667%;" width="71">2</td>
</tr>
<tr>
<td style="width: 183.185%;" colspan="3" width="567"><strong><em>Miscellaneous others</em></strong></td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Acetylcysteine</td>
<td style="width: 67.4607%;" width="374">Mucolytic; symptomatic relief; oral N-acetylcysteine <a href="https://www.ncbi.nlm.nih.gov/pubmed/28258325">ameliorated</a> the intestinal effects of porcine epidemic diarrhea coronavirus in piglets</td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Angiotensin receptor blockers</td>
<td style="width: 67.4607%;" width="374">Antagonists at angiotensin receptors (see ACE inhibitors)</td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122"><span style="font-weight: 400;">Angiotensin converting enzyme (ACE) inhibitors</span></td>
<td style="width: 67.4607%;" width="374"><span style="font-weight: 400;">To be used in at least one study in individuals with hypertension in addition to COVID-19; ACE-2, which facilitates the entry of 2019-nCoV into cells is not inhibited by ACE inhibitors </span></td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Bismuth potassium citrate</td>
<td style="width: 67.4607%;" width="374">Inhibits growth of <em>Helicobacter pylori</em>; used in peptic ulceration; may <a href="https://www.ncbi.nlm.nih.gov/pubmed/17957304">inhibit</a> SARS-CoV1 helicase</td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Bromhexine hydrochloride</td>
<td style="width: 67.4607%;" width="374">Mucolytic; symptomatic relief; small trials in other respiratory disorders show only <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359817/pdf/40248_2017_Article_88.pdf">modest benefit</a>.</td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Diammonium glycyrrhizinate</td>
<td style="width: 67.4607%;" width="374">Derivative of glycyrrhetinic acid used in Chinese medicine; a competitive inhibitor of high mobility group box-1; <a href="https://www.ncbi.nlm.nih.gov/pubmed/28175983">causes</a> moderate inhibition of the porcine epidemic diarrhea coronavirus in vitro, with inhibition of entry of the virus into Vero cells and replication</td>
<td style="width: 91.4667%;" width="71">2</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Dipyridamole</td>
<td style="width: 67.4607%;" width="374">Antiplatelet action by inhibition of adenosine uptake; also inhibits cGMP-phosphodiesterase, augmenting the increase in cGMP produced by EDRF (endothelium-derived relaxing factor, nitric oxide); there is a suggestion that antiplatelet agents, including <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883511/">dipyridamole</a>,&nbsp; slow the progress of idiopathic pulmonary fibrosis.</td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Ebastine</td>
<td style="width: 67.4607%;" width="374">Histamine H1 receptor antagonist (antihistamine); presumably intended for symptomatic relief</td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Hydrogen peroxide</td>
<td style="width: 67.4607%;" width="374">Non-specific supposed antiviral action in the throat</td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Inhaled gases</td>
<td style="width: 67.4607%;" width="374">Oxygen, hydrogen, or the combination; symptomatic relief of hypoxia by oxygen; <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005324/">molecular hydrogen</a> is proposed to have an anti-inflammatory effect.</td>
<td style="width: 91.4667%;" width="71">4</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Pirfenidone</td>
<td style="width: 67.4607%;" width="374"><a href="https://err.ersjournals.com/content/errev/20/120/85.full.pdf">Various mechanisms proposed</a>; reduces fibroblast proliferation, production of fibrosis-associated proteins and cytokines, and increased biosynthesis and accumulation of extracellular matrix in response to cytokine growth factors such as transforming growth factor-beta (TGF-&beta;) and platelet-derived growth factor (PDGF); used to treat idiopathic pulmonary fibrosis</td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Polyinosinic-
<p>polycytidylic acid</p></td>
<td style="width: 67.4607%;" width="374">Analogue of double-stranded RNA; reportedly has agonist actions at: t<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694181/">oll-like receptors TLR-3</a>; retinoic acid inducible gene I (RIG-I)-like receptors; and melanoma differentiation-associated gene 5 (MDA5); <a href="https://www.ncbi.nlm.nih.gov/pubmed/30473353">reduces</a> the amount of mRNA in vitro in PK-15 cells infected with transmissible gastroenteritis coronavirus;&nbsp;&nbsp; <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511752/pdf/ajtr0011-1919.pdf">used in China to treat tumours</a>; to be used in combination with vitamin C</td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">rhG-CSF</td>
<td style="width: 67.4607%;" width="374"><span style="font-weight: 400;">Recombinant human granulocyte colony-stimulating factor; its counterpart, granulocyte macrophage-colony stimulating factor, directs the activation, proliferation, and differentiation of myeloid-derived cells and causes maturation of antigen-presenting cells, </span><a href="https://pubmed.ncbi.nlm.nih.gov/31676420"><span style="font-weight: 400;">thus</span></a><span style="font-weight: 400;"> affecting adaptive immune responses; the 3C-like protease of SARS-CoV-1 </span><a href="https://pubmed.ncbi.nlm.nih.gov/21324206"><span style="font-weight: 400;">reduces expression</span></a><span style="font-weight: 400;"> of granulocyte-macrophage colony-stimulating factor (GM-CSF) in transfected cells in vitro</span></td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Thymosin</td>
<td style="width: 67.4607%;" width="374">A group of polypeptides, initially isolated from the thymus. They are involved in T-cell differentiation. There have been<a href="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003993.pub3/epdf/full" class="broken_link"> trials of their use in cancer treatment</a>, with little evidence of benefit.</td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Tranilast</td>
<td style="width: 67.4607%;" width="374">Tryptophan analogue; anti-allergic, <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842943/">inhibits NLRP3</a> in the inflammasome pathway; used to treat bronchial asthma, atypical dermatitis, allergic conjunctivitis, keloid, and hypertrophic scars</td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Vitamin C</td>
<td style="width: 67.4607%;" width="374">Antioxidant; <a href="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000980.pub2/full" class="broken_link">no evidence</a> to support purported efficacy in any condition other than vitamin C deficiency; very high doses can cause <a href="https://www.ncbi.nlm.nih.gov/pubmed/1569652">nephrolithiasis</a>.</td>
<td style="width: 91.4667%;" width="71">3</td>
</tr>
<tr>
<td style="width: 183.185%;" colspan="3" width="567"><strong><em>Combination studies not included above</em></strong></td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Adamumab + tozumab</td>
<td style="width: 67.4607%;" width="374">Names not recognized; these may be adalimumab and tocilizumab (qqv)</td>
<td style="width: 91.4667%;" width="71">1</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Interferon &alpha;</td>
<td style="width: 67.4607%;" width="374">Combined with antiviral drugs (lopinavir/ritonavir, ribavirin, umifenovir)</td>
<td style="width: 91.4667%;" width="71">3</td>
</tr>
<tr>
<td style="width: 24.2574%;" width="122">Lopinavir/ritonavir</td>
<td style="width: 67.4607%;" width="374">Combined with other antiviral drugs (emtricitabine and tenofovir)</td>
<td style="width: 91.4667%;" width="71">2</td>
</tr>
<tr>
<td style="width: 24.2574%;"></td>
<td style="width: 67.4607%;"></td>
<td style="width: 91.4667%;"></td>
</tr>
</tbody>
</table>
<p>&nbsp;</p>
<p>To quote the conclusion of the authors of a recent Chinese <a href="https://www.medrxiv.org/content/10.1101/2020.03.01.20029611v1.full.pdf">systematic review</a> of 75 trials listed on the Chinese Clinical Registration Center&rsquo;s website and clinicaltrials.gov, &ldquo;based on the poor quality and small sample size[s] and long completion period[s] [of the registered trials], we will not be able to obtain reliable, high-quality clinical evidence about COVID-19 treatment for quite a long time in the future&rdquo;.</p>
<p>&nbsp;</p>
<table width="0">
<tbody>
<tr>
<td width="567"><strong>Advanced Therapy Medicinal Products under investigation (n=24) (wording taken from the titles of the registered studies)</strong>
<ul>
<li>Aerosol inhalation of vMIP: viral macrophage inflammatory protein</li>
<li>Ankylosaurus; M1 macrophages target</li>
<li>Anti-2019-nCoV inactivated convalescent plasma</li>
<li>Anti-SARS-CoV-2 inactivated convalescent plasma</li>
<li>Biological preparation of human placenta</li>
<li>Convalescent plasma treatment</li>
<li>Cord blood mesenchymal stem cells</li>
<li>Human menstrual blood-derived stem cells</li>
<li>Immunoglobulin from cured patients</li>
<li>Inactivated Mycobacterium vaccine</li>
<li>Infusion of convalescent plasma</li>
<li>Mesenchymal stem cells</li>
<li>Mesenchymal stem cells exosomes atomization</li>
<li>mRNA-1273</li>
<li>NK cells</li>
<li>Plasma treatment</li>
<li>Recombinant cytokine gene-derived protein injection</li>
<li>Regulating intestinal flora</li>
<li>Therapeutic antibody from recovered novel coronavirus pneumonia patients</li>
<li>Umbilical cord blood mononuclear cells</li>
<li>Umbilical cord mesenchymal stem cells (hucMSCs)</li>
<li>Umbilical cord Wharton&rsquo;s Jelly derived mesenchymal stem cells</li>
<li>Umbilical Cord(UC)-derived mesenchymal stem cells</li>
<li>Washed microbiota transplantation</li>
</ul>
</td>
</tr>
</tbody>
</table>
<p>&nbsp;</p>
<hr>
<p><strong><em>Carl Heneghan</em></strong><em> is the Editor in Chief </em><a href="https://ebm.bmj.com/content/22/6/202"><em>BMJ EBM</em></a><em> and Professor of EBM, Centre for Evidence-Based Medicine in the Nuffield Department of Primary Care Health Sciences, University of Oxford </em></p>
<p><strong><em>Competing interests: </em></strong><em>CH has received expenses and fees for his media work. He holds grant funding from the NIHR, the NIHR School of Primary Care Research and the NIHR Oxford BRC. CH is also Director of CEBM, which jointly runs the </em><a href="http://evidencelive.org/"><em>EvidenceLive</em></a><em> Conference with the BMJ and the </em><a href="http://www.preventingoverdiagnosis.net/"><em>Overdiagnosis Conference</em></a><em> with international partners, based on a&nbsp; non-profit making model. </em></p>
<p><strong><em>Jeffrey Aronson</em></strong><em> is a physician and clinical pharmacologist working in the Centre for Evidence-Based Medicine in the Nuffield Department of Primary Care Health Sciences, University of Oxford. He is an Associate Editor of BMJ EBM and a President Emeritus of the British Pharmacological Society.</em></p>
<p><strong><em>Competing interests: </em></strong><em>JKA has written papers on the subject of clinical trials and has written papers and edited textbooks on clinical pharmacology, pharmacovigilance, and adverse drug reactions.</em></p>
<p><strong><em>Robin Ferner</em></strong><em> is a clinical pharmacologist at the School of Clinical and Experimental Medicine, University of Birmingham</em></p>
<p><strong><em>Competing interests: </em></strong><em>No competing interests</em></p>
<p><strong><em>Nicholas J DeVito </em></strong><em>is a researcher at the EBM Datalab at the University of Oxford.</em></p>
<p><strong>Competing interests:</strong> ND is employed on an LJAF grant and is a Naji Foundation Scholar at the University of Oxford.</p>
<p>&nbsp;</p>
<p><em>&nbsp;</em></p>
<p>&nbsp;</p>
</body></html>
<div class="swp-content-locator"></div>		
					
	</div>
	<div class="four columns">
          <div class="swp_social_panel swp_horizontal_panel swp_flat_fresh  swp_default_full_color swp_individual_full_color swp_other_full_color scale-100  scale-" data-min-width="1100" data-float-color="#ffffff" data-float="none" data-float-mobile="none" data-transition="fade" ><div class="nc_tweetContainer swp_share_button swp_twitter" data-network="twitter"><a class="nc_tweet swp_share_link" rel="nofollow noreferrer noopener" target="_blank" href="https://twitter.com/intent/tweet?text=COVID-19+Registered+Trials+-+and+analysis&url=https%3A%2F%2Fwww.cebm.net%2Foxford-covid-19%2Fcovid-19-registered-trials-and-analysis%2F&via=cebmoxford" data-link="https://twitter.com/intent/tweet?text=COVID-19+Registered+Trials+-+and+analysis&url=https%3A%2F%2Fwww.cebm.net%2Foxford-covid-19%2Fcovid-19-registered-trials-and-analysis%2F&via=cebmoxford"><span class="swp_count swp_hide"><span class="iconFiller"><span class="spaceManWilly"><i class="sw swp_twitter_icon"></i><span class="swp_share">Tweet</span></span></span></span></a></div><div class="nc_tweetContainer swp_share_button swp_facebook" data-network="facebook"><a class="nc_tweet swp_share_link" rel="nofollow noreferrer noopener" target="_blank" href="https://www.facebook.com/share.php?u=https%3A%2F%2Fwww.cebm.net%2Foxford-covid-19%2Fcovid-19-registered-trials-and-analysis%2F" data-link="https://www.facebook.com/share.php?u=https%3A%2F%2Fwww.cebm.net%2Foxford-covid-19%2Fcovid-19-registered-trials-and-analysis%2F"><span class="swp_count swp_hide"><span class="iconFiller"><span class="spaceManWilly"><i class="sw swp_facebook_icon"></i><span class="swp_share">Share</span></span></span></span></a></div><div class="nc_tweetContainer swp_share_button swp_linkedin" data-network="linkedin"><a class="nc_tweet swp_share_link" rel="nofollow noreferrer noopener" target="_blank" href="https://www.linkedin.com/cws/share?url=https%3A%2F%2Fwww.cebm.net%2Foxford-covid-19%2Fcovid-19-registered-trials-and-analysis%2F" data-link="https://www.linkedin.com/cws/share?url=https%3A%2F%2Fwww.cebm.net%2Foxford-covid-19%2Fcovid-19-registered-trials-and-analysis%2F"><span class="swp_count swp_hide"><span class="iconFiller"><span class="spaceManWilly"><i class="sw swp_linkedin_icon"></i><span class="swp_share">Share</span></span></span></span></a></div></div>          <aside class="sidebar">
        <div style="background-color: #EEEDED;">
        <h4 style="background-color: #731744; padding: 10px; color: white; border-bottom: 0; text-align: center;">What&rsquo;s on</h4>
        <ul style="padding: 10px;">
                <li style="padding: 5px 10px;"><p style="margin-top: 10px;"><a href="https://www.cebm.net/events/preventing-overdiagnosis-2018/" style="color: #731744; font-weight: 700; margin-bottom: 0;">Preventing Overdiagnosis 2020</a>
                <div style="font-weight: 700; font-style: italic; padding: 0; margin: 0 0 10px 0">14 - 16 September 2020</div>
               The 8th international conference in Oxford, UK.</p></li>
                                <li style="padding: 5px 10px;"><p style="margin-top: 10px;"><a href="https://www.cebm.net/events/teaching-ebm/" style="color: #731744; font-weight: 700; margin-bottom: 0;">Teaching EBM 2020</a>
                <div style="font-weight: 700; font-style: italic; padding: 0; margin: 0 0 10px 0">14 - 18 September 2020</div>
               Workshop for health professionals developing their teaching of EBM.</p></li>
                        <li style="padding: 5px 10px;"><a href="/events/" class="btn red" style="width: 100; display:block; text-align:center;">View all</a></li>
        </ul>
           </div>
        
        <p><br/></p>
    
    </aside>
      </div>

</div>
</section>


<footer>
  <div class="container">
    <div class="footer-logo eight columns">
     <img src="https://www.cebm.net/wp-content/themes/cebm-redux/images/primary-care-logo.png" alt="Nuffield Department of Primary Care Health Sciences" />
    </div>
    <div class="footer-sitemap eight columns">
        
        <a href="https://twitter.com/cebmoxford/" target="_blank"><img src="https://www.cebm.net/wp-content/themes/cebm-redux/images/twitter.png" style="float: right; margin-left: 10px;"/></a>
<!--          <img src="https://www.cebm.net/wp-content/themes/cebm-redux/images/facebook.png" style="float:right;" /> --><br/><br/>
        <div class="clearfix"></div>
      <span style="font-size: 14px;"><div class="menu-footer-container"><ul id="menu-footer" class="menu"><li id="menu-item-12062" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-12062"><a href="https://www.cebm.net/about-us/">About us</a></li>
<li id="menu-item-52" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-52"><a href="https://www.cebm.net/contact/">Contact</a></li>
<li id="menu-item-53" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-53"><a href="https://www.cebm.net/privacy/">Privacy</a></li>
<li id="menu-item-54" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-54"><a href="https://www.cebm.net/terms-conditions/">Terms &#038; Conditions</a></li>
</ul></div>&copy; 2020 Centre for Evidence-Based Medicine</span>
    </div>
  </div>
</footer>
</body>

<!-- ================ JS ================ -->
<script src="//ajax.googleapis.com/ajax/libs/jquery/1/jquery.min.js"></script>
<script src="https://www.cebm.net/wp-content/themes/cebm-redux/js/modernizr.js"></script>
<script src="https://www.cebm.net/wp-content/themes/cebm-redux/js/cebm.js"></script>
<script src="//code.jquery.com/ui/1.10.3/jquery-ui.js"></script>
  <script>
  $(function() {
    $( "#tabs" ).tabs();
    
    if($('#datepicker'))
    {
        $('.datepicker').datepicker({ altField: '#date', altFormat: 'yy-mm-dd', dateFormat: 'dd/mm/yy' });
    }
        
    $(window).scroll(function() {  
       var scroll = $(window).scrollTop();
          if (scroll > 306) {
            $("#mainMenu").addClass("sticky-header");
          } else {
            $("#mainMenu").removeClass("sticky-header");
          }          
    });
    
  });
  </script>

<link rel='stylesheet' id='subscribe-and-connect-theme-circular-css'  href='https://www.cebm.net/wp-content/plugins/subscribe-and-connect/assets/css/themes/circular.css?ver=017968d019780d65daeb52a762ad0f3c' type='text/css' media='all' />
<script type='text/javascript'>
/* <![CDATA[ */
var socialWarfare = {"addons":null,"post_id":"14134","floatBeforeContent":""};
/* ]]> */
</script>
<script type='text/javascript' src='https://www.cebm.net/wp-content/plugins/social-warfare/assets/js/script.min.js?ver=3.6.1'></script>
<script type='text/javascript' src='https://www.cebm.net/wp-includes/js/jquery/ui/core.min.js?ver=1.11.4'></script>
<script type='text/javascript' src='https://www.cebm.net/wp-includes/js/jquery/ui/datepicker.min.js?ver=1.11.4'></script>
<script type='text/javascript'>
jQuery(document).ready(function(jQuery){jQuery.datepicker.setDefaults({"closeText":"Close","currentText":"Today","monthNames":["January","February","March","April","May","June","July","August","September","October","November","December"],"monthNamesShort":["Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"nextText":"Next","prevText":"Previous","dayNames":["Sunday","Monday","Tuesday","Wednesday","Thursday","Friday","Saturday"],"dayNamesShort":["Sun","Mon","Tue","Wed","Thu","Fri","Sat"],"dayNamesMin":["S","M","T","W","T","F","S"],"dateFormat":"MM d, yy","firstDay":1,"isRTL":false});});
</script>
<script type='text/javascript' src='https://www.cebm.net/wp-content/plugins/google-calendar-events/assets/js/vendor/jquery.qtip.min.js?ver=3.1.22'></script>
<script type='text/javascript' src='https://www.cebm.net/wp-content/plugins/google-calendar-events/assets/js/vendor/moment.min.js?ver=3.1.22'></script>
<script type='text/javascript' src='https://www.cebm.net/wp-content/plugins/google-calendar-events/assets/js/vendor/moment-timezone-with-data.min.js?ver=3.1.22'></script>
<script type='text/javascript'>
/* <![CDATA[ */
var simcal_default_calendar = {"ajax_url":"\/wp-admin\/admin-ajax.php","nonce":"3837f015a9","locale":"en_GB","text_dir":"ltr","months":{"full":["January","February","March","April","May","June","July","August","September","October","November","December"],"short":["Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"]},"days":{"full":["Sunday","Monday","Tuesday","Wednesday","Thursday","Friday","Saturday"],"short":["Sun","Mon","Tue","Wed","Thu","Fri","Sat"]},"meridiem":{"AM":"AM","am":"am","PM":"PM","pm":"pm"}};
/* ]]> */
</script>
<script type='text/javascript' src='https://www.cebm.net/wp-content/plugins/google-calendar-events/assets/js/default-calendar.min.js?ver=3.1.22'></script>
<script type='text/javascript'>
/* <![CDATA[ */
var wpgdprcData = {"ajaxURL":"https:\/\/www.cebm.net\/wp-admin\/admin-ajax.php","ajaxSecurity":"23ddd52a81","isMultisite":"1","path":"\/","blogId":"1"};
/* ]]> */
</script>
<script type='text/javascript' src='https://www.cebm.net/wp-content/plugins/wp-gdpr-compliance/assets/js/front.js?ver=1559664997'></script>
<script type='text/javascript' src='https://www.cebm.net/wp-content/plugins/google-calendar-events/assets/js/vendor/imagesloaded.pkgd.min.js?ver=3.1.22'></script>
<script type='text/javascript' src='https://www.cebm.net/wp-includes/js/wp-embed.min.js?ver=017968d019780d65daeb52a762ad0f3c'></script>
<script type="text/javascript"> var swp_nonce = "1238a53868";var swpFloatBeforeContent = false;var swpClickTracking = false;</script></html>